UTHSC In the Media


Dr. Srishti Sareen, Joins West Cancer Center and Research Institute

In the Media Icon

Dr. Srishti Sareen, joined West Cancer Center & Research Institute in September 2026, specializing in breast cancer with additional interests in cancer disparities and precision oncology.


Interventional Thyroidology and The Art of Treating Thyroid Disease

In the Media Icon

A fast-growing, multidisciplinary area of endocrinology that uses minimally invasive, image-guided procedures to diagnose and treat thyroid disorders is increasingly being practiced in Memphis, and Malini Gupta, MD, is promoting its use.


Agios to Highlight Strength and Differentiation of Rare Hematology Portfolio with New Clinical Data for Mitapivat in Sickle Cell Disease and AG-236 in Polycythemia Vera at ASH 2026

In the Media Icon

Mitapivat is associated with early and sustained improvements in eGFR among patients with sickle cell disease: A post hoc analysis of the Phase 3 RISE UP trial | Kenneth Ataga, M.D., Center for Sickle Cell Disease at University of Tennessee Health Science Center


Memphis can help national shortage of medical devices for kids, experts say

In the Media Icon

Healthcare officials, investors and clinicians were in Memphis on Wednesday, Nov. 4, to discuss the opportunities available in pediatric medical device innovation as the region and nation face a critical shortage.


Kingsport Economic Development Board continues dental clinic talk

In the Media Icon

During Tuesday’s meeting, the Kingsport Economic Development Board approved up to $250,000 for the second phase of the Kingsport Dental Clinic of the Appalachian Highlands.


Agios to Highlight Strength and Differentiation of Rare Hematology Portfolio with New Clinical Data for Mitapivat in Sickle Cell Disease and AG-236 in Polycythemia Vera at ASH 2026

In the Media Icon

14 abstracts accepted at ASH 2026, including three oral presentations featuring new data across mitapivat clinical programs


San Rocco Therapeutics Announces Major Advances Toward Clinical Development of MiNiRoLu™ Gene Therapy at ESGCT 2026

In the Media Icon

New manufacturing and therapeutic protein expression data support advancement of an investigational gene therapy for sickle cell disease and beta-thalassemia


San Rocco Therapeutics Announces Major Advances Toward Clinical Development of MiNiRoLu™ Gene Therapy at ESGCT 2026

In the Media Icon

New manufacturing and therapeutic protein expression data support advancement of an investigational gene therapy for sickle cell disease and beta-thalassemia